Adjunctive Molecular Hydrogen Therapy Modulates T Cell Markers and Reduces Anti-Ro Antibody in Refractory Oral Ulcers of Behçet's Disease and Sjögren's Syndrome: A Case Report.

Lin CC, Lu JW, Ho YJ, Lui SW, Hsieh TY, Wang KY, Liu FC

Open source

DOI
10.21873/invivo.14274
Published
2026 Mar-Apr
Container
In vivo (Athens, Greece)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.21873/invivo.14274,
  title = {Adjunctive Molecular Hydrogen Therapy Modulates T Cell Markers and Reduces Anti-Ro Antibody in Refractory Oral Ulcers of Behçet's Disease and Sjögren's Syndrome: A Case Report.},
  author = {Lin CC and Lu JW and Ho YJ and Lui SW and Hsieh TY and Wang KY and Liu FC},
  year = {2026},
  journal = {In vivo (Athens, Greece)},
  doi = {10.21873/invivo.14274},
  url = {https://doi.org/10.21873/invivo.14274}
}

RIS

TY  - JOUR
TI  - Adjunctive Molecular Hydrogen Therapy Modulates T Cell Markers and Reduces Anti-Ro Antibody in Refractory Oral Ulcers of Behçet's Disease and Sjögren's Syndrome: A Case Report.
AU  - Lin CC
AU  - Lu JW
AU  - Ho YJ
AU  - Lui SW
AU  - Hsieh TY
AU  - Wang KY
AU  - Liu FC
PY  - 2026
JO  - In vivo (Athens, Greece)
DO  - 10.21873/invivo.14274
UR  - https://doi.org/10.21873/invivo.14274
ER  - 

APA

CC, L., JW, L., YJ, H., SW, L., TY, H., KY, W., & FC, L. (2026). Adjunctive Molecular Hydrogen Therapy Modulates T Cell Markers and Reduces Anti-Ro Antibody in Refractory Oral Ulcers of Behçet's Disease and Sjögren's Syndrome: A Case Report.. In vivo (Athens, Greece). https://doi.org/10.21873/invivo.14274

Source records